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Abstract
Background: Since Mycobacterium avium subspecies paratuberculosis (MAP) was isolated from
intestinal tissue of a human patient suffering Crohn's disease, a controversial discussion exists
whether MAP have a role in the etiology of Crohn's disease or not. Raw milk may be a potential
vehicle for the transmission of MAP to human population. In a previous paper, we have
demonstrated that MAP are found in raw milk samples obtained from a defined region in
Switzerland. The aim of this work is to collect data about the prevalence of MAP specific IS900
insertion sequence in bulk-tank milk samples in different regions of Switzerland. Furthermore, we
examined eventual correlation between the presence of MAP and the somatic cell counts, the total
colony counts and the presence of Enterobacteriaceae.
Results: 273 (19.7%) of the 1384 examined bulk-tank milk samples tested IS900 PCR-positive. The
prevalence, however, in the different regions of Switzerland shows significant differences and
ranged from 1.7% to 49.2%. Furthermore, there were no statistically significant (p >> 0.05)
differences between the somatic cell counts and the total colony counts of PCR-positive and PCR-
negative milk samples. Enterobacteriaceae occur as often in IS900 PCR-positive as in PCR-negative
milk samples.
Conclusion: This is the first study, which investigates the prevalence of MAP in bulk-tank milk
samples all over Switzerland and infers the herd-level prevalence of MAP infection in dairy herds.
The prevalence of 19.7% IS900 PCR-positive bulk-milk samples shows a wide distribution of
subclinical MAP-infections in dairy stock in Switzerland. MAP can therefore often be transmitted
to humans by raw milk consumption.
Background
MAP belongs to the slow growing mycobacteria in the ge-
nus  Mycobacterium. The cell envelope of mycobacteria
contains a high proportion of lipids that make them re-
sistant to dye extraction by acid-alcohol (acid-fast in
Ziehl-Neelsen stain). This high proportion of lipids plays
a crucial role in the adaptation of mycobacteria to intrac-
ellular growth in macrophages as well as in drug resistance
[1]. Various mycobacterial species contain a number of
highly specific insertion sequences (IS) integrated in the
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genome [1]. Some of those genetic elements can be used
to disthiguish species of mycobacteria [2–4].
MAP belongs to the M. avium-complex and has specific
characteristics: mycobactin-dependence very slow growth
(incubation of the cultures for 16 weeks), and a tendency
to form large clumps [5]. The specific insertion sequence
of MAP is the IS900 element [6–8].
In ruminants, infection by MAP causes paratuberculosis, a
granulomatous enteritis which is responsible for impor-
tant economic losses through production losses and pre-
mature culling [9–12]. Paratuberculosis is prevalent in
domestic ruminants worldwide and occurs also in other
domesticated, wild and zoo animals including primate
[13]. It is principally a subclinical infection with a long in-
cubation period. Clinical signs are only seen in a minority
of infected animals [14]. MAP is shed intermittently by
subclinically and clinically infected cows into manure and
within macrophages in milk [15,16]. Subclinical shedders
are the main problem because they have no clinical signs
and contaminate the environment with MAP, which rep-
resents a source for new infections.
Crohn's disease, a chronic granulomatous, incurable ileo-
colitis of humans, has significant similarity to the pau-
cimicrobial form of paratuberculosis in animals [17].
Chiodini et al. [10] isolated MAP from intestinal tissue of
a human patient suffering Crohn's disease. Since then, a
controversial discussion exists whether MAP plays a role
in the etiology of Crohn's disease or not [4,17–19]. Re-
cently, research is making advances in understanding
MAP-infections, and is indicating more and more that at
least some cases of Crohn's disease may be caused by this
organism [20].
Raw milk may be a potential vehicle for the transmission
of MAP to human population. Sweeney et al. [21] found,
that MAP is shed into milk by 12% of subclinically infect-
ed cows in a concentration of 2 to 8 CFU per 50 ml milk.
Moreover, results of laboratory pasteurization tests of
whole milk spiked with MAP showed that MAP was capa-
ble of surviving pasteurization of raw milk [22–25]. Nev-
ertheless, literature data are very divergent. Sung et al. [26]
reported a D-value (decimal reduction time) for MAP in
milk of 11 sec at 71°C, so there is a possibility for MAP to
survive HTST (high temperature short time) pasteuriza-
tion if the initial number is >101 cfu ml-1 milk. Pearce et
al. [27], however, found a D-value of 2.03 sec at 72°C,
which is equivalent to a >7 log10 reduction at 72°C for 15
sec (HTST pasteurization). In a study of whole-pasteur-
ized cows milk obtained from retail outlets in England 7%
of these samples tested MAP-positive (IS900-positive) by
PCR [28]. Grant et al. [29] pasteurized raw cows' milk nat-
urally infected with MAP and found, that MAP is capable
of surviving commercial scale pasteurization at 73°C for
15 s and 25 s with and without prior homogenization if
the bacterial cells are present in sufficient numbers before
heat treatment. They also tested commercially pasteurized
cows' milk samples from dairy processing establishments
for the present of MAP by culture. 1.8% of the tested pas-
teurized milk samples were MAP-positive [30]. Further-
more, the production process for hard and semihard raw
milk cheese seems not to completely reduce MAP. Spahr
and Schafroth [31] found D-values of 27.7 days for hard
and 45.5 days for semihard cheese manufactured of artifi-
cially contaminated raw milk.
The aim of this study was to collect data about the preva-
lence of the MAP specific IS900 insertion sequence in
bulk-tank milk samples from different regions of Switzer-
land. Furthermore, we examined eventual correlation be-
tween the presence of MAP and the somatic cell counts,
the total colony counts and the presence of Enterobacte-
riaceae in bulk-tank milk samples.
Results
273 (19.7%) of the 1384 milk samples were IS900 PCR-
positive. PCR amplification of the MAP specific insertion
sequence IS900 and subsequent agarose gel analysis of the
amplified products showed a single band of 298 bp for
each of the positive milk samples (Fig. 1). The PCR prod-
ucts, however, differed in intensity.
The prevalence of IS900-containing milk samples in the
18 regions of Switzerland were different (Fig. 2). In five re-
gions in different parts of Switzerland, prevalence ranging
from 29.5% to 49.2%, in eight regions, situated in the
center, the east and one of them in the northwest part of
Figure 1
Agarose gel electrophoresis of PCR products obtained from
different bulk-tank milk samples following IS900 nested PCR.
M: 100 bp molecular wight ladder (Roche Diagnostics,
Rotkreuz, Switzerland). Lanes 1, 2, 4, 5, 9, 10: positive sam-
ples with a specific amplification product of 298 bp. Lanes 3,
6, 7, 8: negative samples. +: positive control with IS900
nested product of 298 bp in length and additional higher
molecular weight amplification products at 350 bp, 400 bp
and 700 bp. -: negative control.
M 1 234 56-789 1 0 -+-
bp
1000
500
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Switzerland, only prevalence from 1.7% to 14.3% were
found.
The results of somatic cell counts ranged from 11'000 cells
ml-1 to 981'000 cells ml-1, with mean value of 130'670
cells ml-1. In 42 (3.5%) milk samples, the somatic cell
counts were higher than the Swiss legal limit of 350'000
cells ml-1.
Results of total colony counts ranged from 1.2 ×  102 CFU
ml-1 to 1.2 ×  106 CFU ml-1, with mean value of 2 ×  104
CFU ml-1.  Enterobacteriaceae could be found in 237
(52.7%) of 450 investigated milk samples with colony
counts ranging from 1 CFU ml-1 to 2 ×  103 CFU ml-1.
Discussion
Positive IS900 PCR results provide presumptive evidence
of the presence of MAP. The prevalence of 19.7% IS900
PCR-positive bulk-milk samples shows a wide distribu-
tion of subclinical MAP-infections in dairy stock in Swit-
zerland. Since not all animals which are subclinically
infected with MAP shed the organism in the milk and
moreover this excretion is intermittent, it is probable that
there are stocks with subclinically infected animals which
haven't at the time of sample collection shed MAP in the
milk. It is therefore possible that the prevalence of sub-
clinically infected dairy stocks is even higher than we have
found.
Moreover, there are distinct regional differences (Fig. 2)
which are statistically (chi square-test) significant (p <
0.05). However, there is no explanation for these regional
differences, even no difference between the mountain and
the plains could be found. Conspicuous regional differ-
ences in the distribution of prevalence have previously
been described in other countries [32,33].
The differences in the intensity of the PCR-amplicons can
be explained by different concentrations of MAP in the
bulk-tank milk samples.
For Switzerland, actually no other comparative data on
the occurrence of MAP in milk samples exist. In two stud-
ies ELISA serology test results of Swiss milk cows are avail-
able. Meylan et al. [34] described a seroprevalence of 4.9%
by examining 595 animals in one defined region of Swit-
Figure 2
Prevalence of the MAP specific IS900 insertion sequence in bulk-tank milk samples in different regions of Switzerland (  high
prevalence;   medium prevalence;   low prevalence)
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zerland. This study, however, concern with animal-level
prevalence which is generally lower compared to herd-lev-
el prevalence. Stärk et al. [35] found a herd-level preva-
lence of 8.0% by investigating 113 stocks. In there study,
however, no information is given about the geographic
distribution of positive herds.
From some other countries herd-level data are available
too (Table 1). Similar to our own study, Nielsen et al.
[36,37] examined bulk-tank milk samples from six differ-
ent regions in Denmark. They performed an ELISA test on
900 bulk-tank milk samples and detected a herd-level
prevalence of 47% (423 MAP-antibody-positive samples).
Grant  et al. [30] performed an immunomagnetic PCR
method on 244 bulk-tank milk samples from the United
Kingdom and detected a herd-level prevalence of 7.8%
(19 PCR-positive samples). In all other studies MAP anti-
bodies were proofed in serum with ELISA-systems. The
prevalence range from 6.96% to 54.7% in Europe, and
from 43.3% to 55.4% in North America. These results
show, that MAPis widely spread in northern Europe and
in North America.
There were no statistically significant (p >> 0.05) differ-
ences between the somatic cell counts and the total colony
counts of PCR-positive and PCR-negative milk samples by
the Mann-Whitney-test (Fig. 3). Therefore, there is no cor-
relation between the presence of MAP, the somatic cell
counts or total colony counts. Enterobacteriaceae occur as
often in IS900 PCR-positive milk as in PCR-negative sam-
ples. McNab et al. [38] and Nordlund et al. [39] found
similar results.
Today it seems more and more probable that MAP could
play a role in the etiology of Crohn's disease. But, many
questions remain unanswered: minimal infection dose,
concentration of MAP in the raw milk of subclinically in-
fected cattle, heat resistance under commercial condi-
tions, exact pathogenesis of Crohn's disease and
paratuberculosis. Only the answers to these questions will
allow an assessment of the risk associated with consump-
tion of raw and pasteurised milk. It is especially important
to investigate survive of MAP in the commercial pasteuri-
zation process by using naturally infected milk. Under
laboratory conditions, the milk is in a quiescent state and
not subjected to the turbulent flow. MAPwhich were used
in the experiments were mostly present as single cells and
in high concentrations. In naturally infected milk, howev-
er, MAP occur in low concentration and in clumps, which
are enclosed in macrophages.
Conclusions
This is the first study, which investigates the herd-level
prevalence of MAP all over Switzerland. Positive IS900
PCR results do provide presumptive evidence of the pres-
ence of MAP. The prevalence of 19.7% IS900 PCR-positive
bulk-milk samples shows a wide distribution of subclini-
cal MAP-infections in dairy stock in Switzerland. MAP can
therefore often be transmitted to humans by raw milk
consumption. Furthermore, there were no statistically sig-
nificant (p >> 0.05) differences between the somatic cell
counts and the total colony counts of PCR-positive and
PCR-negative milk samples Enterobacteriaceae occur as of-
ten in IS900 PCR-positive as in PCR-negative milk sam-
ples.
Materials and Methods
Material
Between February and June 2001, 1384 bulk-tank milk
samples were collected from 18 different regions all over
Table 1: Herd-level prevalence of MAP in dairy stock (literature data)
origin material method number of investi-
gated herds
herd prevalences reference
Denmark Bulk-tank milk sam-
ples
ELISA 900 47% [36,37]
UK Bulk-tank milk sam-
ples
PCR 244 7.8% [30]
Austria Serum samples ELISA 2757 6.96%a [33]
Belgian Serum samples ELISA 464 18% [41]
Netherlands Serum samples ELISA 378 54.7% [42]
Canada Serum samples ELISA 90 43.3% [43]
Missouri Serum samples ELISA 89 47% [44]
Wisconsin Serum samples ELISA 158 50%b [32]
Michigan Serum samples ELISA 121 55.4% [45]
a 4–13% in different regions. b more infected herds in the southern and western districtsBMC Microbiology 2002, 2 http://www.biomedcentral.com/1471-2180/2/15
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Switzerland, with 41 to 100 samples per region. The sam-
ples were taken aseptically from diverse milk inspection
services and brought cooled to the laboratory. Total colo-
ny counts and Enterobacteriaceae counts were done direct-
ly. For the detection of MAP, 20 ml milk was stored at -
20°C up to investigation. Conservation of milk samples
for somatic cell counts was done by adding 100 µl 4%
Bronopol (Fluka, Buchs, Switzerland) to 10 ml milk.
Mycobacterial lysis
10 ml of each milk sample were mixed with 100 µl Triton®
X-100 (Calbiochem, Darmstadt, Germany) and centri-
fuged at 4500 rpm for 30 min. Cream and whey were dis-
carded, the pellet was frozen, transferred to a blue
ribolyser tube (Hybaid, Ashford, United Kingdom), resus-
pended in 400 µl mycobacterial lysis buffer (86.6 ml
H2O, 8 ml 5 M NaCL, 2 ml 2 M TrisHCl (pH 8), 3 ml 20%
SDS, 400 µl 0,5 M EDTA, 220 µl 15.6 mg/ml proteinase K
(Roche Diagnostics AG, Rotkreuz, Switzerland)), and in-
cubated overnight at 37°C. MAP DNA was released by me-
chanical disruption of the lysate at 6.5 msec-1 for 45 sec in
a Ribolyser (Hybaid, Ashford). Afterwards, the blue ri-
bolyser tubes were immediately put on ice for 15 min.
DNA extraction
For the DNA extraction, 400 µl phenol were added, the
tubes vortexed for 20 sec, centrifuged at 13000 rpm for 2
min at 4°C, and the aqueous layer was pipetted to a new
tube. The same steps were repeated with phenol/chloro-
form/isoamylalcohol (25:24:1) and chloroform/isoamy-
lalcohol (24:1). To the last aqueous layer, 40 µl 3 M
Sodium acetat and 800 µl ethanol abs. were pipetted. Af-
ter careful mixing, the DNA was precipitated at -70°C, 30
min. Then, the tubes were centrifuged for 20 min at 13000
rpm and 4°C and the supernatant was discarded. The pel-
let was washed with 800 µl ice cold 70% ethanol, the
tubes centrifuged for 5 min at 13000 rpm and 4°C, and
the supernatant discarded. The pellet was dried in a con-
centrator (Vaudaux-Eppendorf, Basel, Switzerland) and
resuspended in 50 µl TE-buffer.
Figure 3
Comparison of total colony counts and somatic cell counts of IS900 PCR-positive and IS900 PCR-negative bulk-tank milk sam-
ples (box plot representation).
1,0E2
1,0E3
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1,0E5
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IS900 nested PCR
5 µl of the resuspended DNA was used for an IS900 nested
PCR specific to MAP. According to Hermon-Taylor et al.
[4], the primers p90 5'-GAA GGG TGT TCG GGG CCG
TCG CTT AGG-3' and p91 5'-GGC GTT GAG GTC GAT
CGC CCA CGT GAC-3' were used for the first 30 amplifi-
cation cycles. The PCR mix consisted of 50 µl reaction vol-
ume containing a final concentration of 2 µM of each
primer, 2.5 mM MgCl2, 100 µM dNTP (Promega, Madi-
son, USA), 2 U Taq polymerase (Promega, Madison) in 1×
reaction buffer (Promega, Madison). Reactions were cy-
cled as follows: 94°C for 5 min (1 cycle); 94°C for 1 min,
58°C for 1 min, 72°C for 3 min (30 cycles); 72°C for 7
min (1 cycle).
2 µl from the primary amplification were then used with
the primers AV1 5'-ATG TGG TTG CTG TGT TGG ATG G-
3' and AV2 5'-CCG CCG CAA TCA ACT CCA G-3' for the
nested-PCR. The PCR mix consisted of 50 µl reaction vol-
ume containing a final concentration of 2 µM of each
primer, 1.5 mM MgCl2, 100 µM dNTP (Promega, Madi-
son), 2 U Taq polymerase (Promega, Madison) in 1×  reac-
tion buffer (Promega, Madison). Reactions were cycled as
follows: 94°C for 5 min (1 cycle); 94°C for 1 min, 58°C for
1 min, 72°C for 3 min (40 cycles); 72°C for 7 min (1 cy-
cle). PCR products were visualized on 1.5% agrose gels
(Eurobio, Les Ulis Cedex, France). The IS900 nested prod-
uct is 298 bp in length but a strong signal will also give
non-specific bands at 350 bp, 400 bp and 700 bp [4]. For
each batch of processed samples negative process controls
and positive bacterial controls were included.
Total colony counts and Enterobacteriaceae counts
Additionally to MAP, total colony counts and Enterobacte-
riaceae counts were determined of 450 milk samples ac-
cording to standard methods on plate count agar (Oxoid,
Basingstoke, United Kindom) and violet red bile glucose
agar (BBL, Cockeysville, USA), respectively.
Somatic cell counts
Of 1212 milk samples somatic cell counts were deter-
mined by a fluorescenceoptic method with a Fossomatic
90 system (Foss Electronic, Hillerod, Danmark) according
to the manufacture's instruction.
Statistical analysis
Total colony counts and somatic cell counts were trans-
formed to log10 values and depicted in box plots. By illus-
trating results in such a way median values, 50%, 75%,
80% and 90% ranges and extreme values can be analysed
more conveniently [40]. Statistical significance was deter-
mined by the chi square-test and the Mann-Whitney-test.
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